Babaran, Geraldine .
HRN: 27-10-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2025
MUPIROCIN 2%, 15G (TUBE)
05/14/2025
05/20/2025
TOPICAL
Pea Size
Od
Post Cs
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes